Drug Shortage Report for AA-THEO LA
| Report ID | 82343 |
| Drug Identification Number | 00692700 |
| Brand name | APO-THEO LA |
| Common or Proper name | THEO LA |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | THEOPHYLLINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 BTL |
| ATC code | R03DA |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-04-22 |
| Estimated end date | Unknown |
| Actual end date | 2019-08-13 |
| Shortage status | Resolved |
| Updated date | 2021-10-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-04-24 | English | Compare |
| v2 | 2019-04-24 | French | Compare |
| v3 | 2021-10-14 | English | Compare |
| v4 | 2021-10-14 | French | Compare |
Showing 1 to 4 of 4